Early research (Phase 1)Study completedNCT00783328What this trial is testingPF-00299804 In Patients In Japan With Advanced Malignant Solid TumorsWho this might be right forNeoplasms Pfizer 13
Early research (Phase 1)Study completedNCT06186492What this trial is testingResearch Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)Who this might be right forAlpha-1 Antitrypsin Deficiency (AATD) Wave Life Sciences USA, Inc. 47
Early research (Phase 1)Study completedNCT01091532What this trial is testingA Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.Who this might be right forPhase 1Multiple DoseSafety+2 more Pfizer 48
Early research (Phase 1)Study completedNCT01336244What this trial is testingGLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic StudyWho this might be right forHealthy Lakefront Biotherapeutics NV 45
Testing effectiveness (Phase 2)Study completedNCT02296775What this trial is testingComparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Dr. Reddy's Laboratories Limited 276
Early research (Phase 1)Study completedNCT03784300What this trial is testingA Safety Study of PTI-125 in Healthy VolunteersWho this might be right forAlzheimer Disease, Early OnsetAlzheimer Disease Pain Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT00663026What this trial is testingStudy Evaluating Bapineuzumab In Alzheimer Disease SubjectsWho this might be right forAlzheimer Disease Pfizer 79
Early research (Phase 1)Study completedNCT02546635What this trial is testingPotential Food Effect And Repeated Dosing of AX-024.HCl In Healthy SubjectsWho this might be right forHealthy Artax Biopharma Inc 32
Early research (Phase 1)Not Yet RecruitingNCT06015568What this trial is testingStudy of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive MutationWho this might be right forNon-Small Cell Lung Cancer、EGFR Sensitive Mutation Betta Pharmaceuticals Co., Ltd. 172
Large-scale testing (Phase 3)Study completedNCT05433350What this trial is testingPharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric PatientsWho this might be right forTrypanosomiasis, AfricanTrypanosoma Brucei Gambiense; InfectionSleeping Sickness Drugs for Neglected Diseases 35
Early research (Phase 1)Study completedNCT02278250What this trial is testingFirst in Human Study of M4344 in Participants With Advanced Solid TumorsWho this might be right forSolid TumorAdvanced Solid Tumor EMD Serono Research & Development Institute, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT01494610What this trial is testingPharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.Who this might be right forAsthma GlaxoSmithKline 60
Early research (Phase 1)Ended earlyNCT06509906What this trial is testingM9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)Who this might be right forAdvanced Solid Tumor EMD Serono Research & Development Institute, Inc. 3
Early research (Phase 1)Study completedNCT05132049What this trial is testingPharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult VolunteersWho this might be right forHealthy Dong-A ST Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT03656510What this trial is testingStudy to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus InfectionWho this might be right forRespiratory Syncytial Virus Infections Janssen Research & Development, LLC 246
Early research (Phase 1)Study completedNCT04334213What this trial is testingA Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150Who this might be right forType 2 Diabetes Chong Kun Dang Pharmaceutical 48
Early research (Phase 1)Study completedNCT05933824What this trial is testingStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy SubjectsWho this might be right forHIV (Human Immunodeficiency Virus) Shanxi Kangbao Biological Product Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT02772276What this trial is testingPharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color TypesWho this might be right forAcute Kidney Injury MediBeacon 234
Early research (Phase 1)Not Yet RecruitingNCT07719218What this trial is testingThe Safety and PK Study of Inhaled ICF004 in Healthy Chinese VolunteersWho this might be right forInterstitial Lung Disease (ILD)Healthy Volunteers Ruijin Hospital 73
Early research (Phase 1)Study completedNCT04047420What this trial is testingSafety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered RectallyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 23